2.3.1.B41	medicine	PfSir2A inhibitors may have therapeutic value in malaria treatment	
2.3.1.B41	medicine	the oncogenic role of SIRT6 in skin cancer suggest SIRT6 as a potential target for developing chemopreventive strategies to reduce the skin cancer	
2.3.1.B41	medicine	the enzyme is a therapeutic target for ovarian cancer therapy	
2.3.1.B41	medicine	SIRT6 and its downstream signaling can be targeted in Alzheimer's disease and age related neurodegeneration	
2.3.1.B41	medicine	SIRT6 as a potential therapeutic target to prevent astrocyte-mediated motor neuron death in amyotrophic lateral sclerosis (ALS)	
2.3.1.B41	medicine	small molecule activators for the human sirtuins Sirt1-7 are sought as chemical tools and potential therapeutics, such as for cancer	
2.3.1.B41	medicine	the enzyme is a potential therapeutic target for therapy of cancer and other metabolic diseases